{"id":836629,"date":"2025-04-11T09:20:22","date_gmt":"2025-04-11T13:20:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/"},"modified":"2025-04-11T09:20:22","modified_gmt":"2025-04-11T13:20:22","slug":"attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/","title":{"rendered":"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf"},"content":{"rendered":"
\n

PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) — <\/p>\n

\n
\n Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss:<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) as an underlying securities fraud class action has survived a motion to dismiss the complaint.<\/strong><\/p>\n

\n If you are a current Axsome (NASDAQ: AXSM) shareholder who purchased Axsome shares prior to May 10, 2021, and still hold shares today, <\/strong>
\n you may be able to <\/strong>
\n seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/axsome-shareholder-investigation\/<\/strong>
\n <\/a>
\n , <\/strong>
\n contact Joshua Grabar at\u00a0<\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n ,<\/strong>
\n or call us at 267-507-6085<\/strong>\n <\/p>\n

\n WHY?:<\/strong> An underlying securities fraud class action complaint alleges that Axsome Therapeutics (NASDAQ: AXSM), via certain of its officers, made false and\/or misleading statements, as well as failed to disclose material adverse facts about the Company\u2019s business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and\/or misleading statements and\/or failed to disclose that: (i) Axsome\u2019s chemistry, manufacturing, and control (“CMC”) practices were deficient with respect to AXS-07 and its manufacturing process; (ii) as a result, Axsome was unlikely to submit the AXS-07 NDA on its initially represented timeline; (iii) the foregoing CMC issues remained unresolved at the time that the FDA reviewed the AXS-07 NDA; (iv) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (v) as a result of all the foregoing, Axsome had overstated AXS-07\u2019s regulatory and commercial prospects; and (vi) as a result, the Company\u2019s public statements were materially false and misleading at all relevant times.<\/p>\n

\n On March 31, 2025, the Court issued an Order denying Axsome’s Motion to Dismiss<\/strong>. The Court determined that the operative complaint sufficiently pleads material misrepresentations or omissions regarding two categories of statements: (1) Defendants\u2019 statements that the manufacturing facility and suppliers for AXS-07 were not experiencing problems and (2) Defendants\u2019 statements about AXS-07\u2019s NDA.\u00a0\u00a0<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong> If you purchased Axsome Therapeutics (NASDAQ: AXSM) prior to May 10, 2021 and still hold shares today, you are encouraged to visit https:\/\/grabarlaw.com\/the-latest\/axsome-shareholder-investigation\/<\/a>, contact Joshua Grabar at jgrabar@grabarlaw.com<\/a>, or call 267-507-6085. You may be able to seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $AXSM #Axsome<\/p>\n

\n
\n Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss:<\/u>
\n <\/strong>\n <\/p>\n

\n A securities fraud class action complaint against <\/strong>
\n Driven Brands Holdings, Inc. (NASDAQ: DRVN) has survived defendants\u2019 attempts to dismiss the complaint. <\/strong>\n <\/p>\n

\n If you have held Driven Brands (NASDAQ: DRVN) shares continuously since prior to <\/strong>
\n October 27, 2021, you can<\/strong>
\n seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you<\/strong>. Visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/driven-brands-shareholder-investigation\/<\/strong><\/a> or <\/strong>contact Joshua H. Grabar at <\/strong>jgrabar@grabarlaw.com<\/strong><\/a> or call 267-507-6085 <\/strong>to learn more.<\/strong><\/p>\n

\n WHY:<\/strong> An underlying securities fraud class action complaint alleges that Driven Brands, through certain of its officers and directors, made numerous materially false and misleading statements and omissions pertaining to: (i) Driven Brands\u2019 ability to efficiently and effectively integrate a high volume of acquired businesses, including statements related to the status of integrating its U.S. auto glass businesses; and (ii) the performance and competitive position of Driven Brands\u2019 car wash business segment.<\/p>\n

On February 20, 2025, a Federal Court determined that the allegations in the plaintiff\u2019s underlying securities fraud class action complaint were adequately pleaded to survive defendants attempts to dismiss the complaint.<\/p>\n

\n WHAT TO DO NOW:<\/strong>
\n If you are a current Driven Brands shareholder who has held Driven Brands shares since prior to October 27, 2021<\/strong>, you <\/strong>can<\/strong> seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong> If you would like to learn more about this matter, you are encouraged to visit <\/strong>https:\/\/grabarlaw.com\/the-latest\/driven-brands-shareholder-investigation\/<\/strong><\/a>, contact Joshua H. Grabar at jgrabar@grabarlaw.com<\/a> or call 267-507-6085. $DRVN #DrivenBrands<\/p>\n

\n
\n Integra LifeSciences Holdings Corp. (NASDAQ: IART):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties owed to the Company.<\/p>\n

\n Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the stock since on or before <\/strong>
\n March 11, 2019<\/strong>
\n , <\/strong>
\n can <\/strong>
\n seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.<\/strong>\u00a0\u00a0 Learn more or join at: <\/strong>https:\/\/grabarlaw.com\/the-latest\/intrga-lifesciences-shareholder-investigation\/<\/strong><\/a>. Contact Joshua H. Grabar at <\/strong>jgrabar@grabarlaw.com<\/strong><\/a>,<\/u><\/strong> or call 267-507-6085<\/strong>.<\/p>\n

\n WHY<\/strong>
\n :<\/strong> An underlying securities fraud class action complaint alleges that Integra, via certain of his officers and directors, repeatedly touted that it was on track to grow SurgiMend\u2019s market by obtaining FDA approval for use in post-mastectomy reconstruction, yet on May 23, 2023, the Company was forced to announce a \u201crecall\u201d of all products manufactured at its Boston Facility between March 1, 2018 and May 22, 2023. Integra LifeSciences explained that it had determined that the Boston Facility deviated from good manufacturing practices in testing for bacterial endotoxin and allowed the release of products with unsafe levels of endotoxins. As a result of the recall and manufacturing shutdown, the Company revised its guidance for the second quarter of 2023, lowering its revenue expectations by and disclosed that it expected to take a $22 million impairment due to the inventory write-off.<\/p>\n

\n WHAT TO DO NOW:<\/strong> Current Integra LifeSciences shareholders who have held Integra LifeSciences shares since on or before March 11, 2019, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.<\/p>\n

\n If you<\/strong>
\n would like to learn more about this matter, you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/intrga-lifesciences-shareholder-investigation\/<\/strong>
\n <\/a>
\n , <\/strong>contact Joshua H. Grabar at jgrabar@grabarlaw.com<\/a>, or call us at 267-507-6085. $IART #IntegraLifeSciences<\/p>\n

\n
\n Virtu Financial Inc. (NASDAQ: VIRT) Class Action Survives Motion to Dismiss:<\/u>
\n <\/strong>\n <\/p>\n

A federal securities fraud class action complaint alleging that Virtu Financial Inc. (NASDAQ: VIRT), and certain of its officers failed to disclose to investors that it had improper safeguards in place for sensitive trader information, has survived a motion to dismiss.<\/p>\n

Virtu shareholders who have continuously held Virtu shares since prior to November 7, 2018<\/strong>, can<\/strong> seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. <\/strong>Learn more or join by clicking https:\/\/grabarlaw.com\/the-latest\/Virtu-shareholder-investigation\/<\/a>, contact Joshua H. Grabar at jgrabar@grabarlaw.com<\/a>, or call 267-507-6085.<\/p>\n

\n WHY<\/strong>: A securities fraud class action complaint alleges that Virtu Financial (NASDAQ: VIRT), via certain of its officers, made false and\/or misleading statements and\/or failed to disclose that: (i) the Company maintained deficient policies and procedures with respect to its information access barriers; (ii) accordingly, Virtu had overstated the Company\u2019s operational and technological efficacy as well as its capacity to block the exchange of confidential information between departments or individuals within the Company; (iii) the foregoing deficiencies increased the likelihood that the Company would be subject to enhanced regulatory scrutiny; and (iv) as a result, Defendants\u2019 public statements were materially false and\/or misleading at all relevant times.<\/p>\n

\n On March 17, 2025, a federal Court determined that key allegations were sufficiently pled to survive defendants\u2019 motion to dismiss. <\/strong>\n <\/p>\n

According to the Court\u2019s Order, “essentially anyone at Virtu, including its proprietary traders” could directly access this material non-public information from at least January 2018 through April 2019, and to do so, Virtu traders only needed to use a “widely known and frequently shared username and password.”<\/p>\n

\n WHAT YOU SHOULD DO NOW: <\/strong>If you are a current Virtu shareholder who has held Virtu stock since on or before November 7, 2018, you can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to you whatsoever.<\/p>\n

\n If you<\/strong>
\n would like to learn more about this matter, you are encouraged visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/Virtu-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua H. Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n or call 267-507-6085. <\/strong>$VIRT #VirtuFinancial<\/p>\n

\n Attorney Advertising Disclaimer<\/a>\n <\/p>\n

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: \u00a0267-507-6085
Email: jgrabar@grabarlaw.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) as an underlying securities fraud class action has survived a motion to dismiss the complaint. If you are a current Axsome (NASDAQ: AXSM) shareholder who purchased Axsome shares prior to May 10, 2021, and still hold shares today, you may be able to seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/axsome-shareholder-investigation\/ , contact Joshua Grabar at\u00a0 jgrabar@grabarlaw.com , or call us at 267-507-6085 WHY?: An underlying securities … <\/p>\n

Continue reading “Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-836629","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAttention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) as an underlying securities fraud class action has survived a motion to dismiss the complaint. If you are a current Axsome (NASDAQ: AXSM) shareholder who purchased Axsome shares prior to May 10, 2021, and still hold shares today, you may be able to seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/axsome-shareholder-investigation\/ , contact Joshua Grabar at\u00a0 jgrabar@grabarlaw.com , or call us at 267-507-6085 WHY?: An underlying securities … Continue reading "Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-11T13:20:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf\",\"datePublished\":\"2025-04-11T13:20:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/\"},\"wordCount\":1413,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/\",\"name\":\"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=\",\"datePublished\":\"2025-04-11T13:20:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/","og_locale":"en_US","og_type":"article","og_title":"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk","og_description":"PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) as an underlying securities fraud class action has survived a motion to dismiss the complaint. If you are a current Axsome (NASDAQ: AXSM) shareholder who purchased Axsome shares prior to May 10, 2021, and still hold shares today, you may be able to seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https:\/\/grabarlaw.com\/the-latest\/axsome-shareholder-investigation\/ , contact Joshua Grabar at\u00a0 jgrabar@grabarlaw.com , or call us at 267-507-6085 WHY?: An underlying securities … Continue reading \"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-11T13:20:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf","datePublished":"2025-04-11T13:20:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/"},"wordCount":1413,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/","name":"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=","datePublished":"2025-04-11T13:20:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMTAxMSM2ODYyNjM5IzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/attention-long-term-shareholders-of-axsome-therapeutics-inc-nasdaq-axsm-driven-bands-holdings-inc-nasdaq-drvn-integra-lifesciences-holdings-corporation-nasdaq-iart-and-virtu-financial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/836629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=836629"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/836629\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=836629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=836629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=836629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}